GO
Loading...

CSL: Seeing strong operational performance

Tuesday, 11 Feb 2014 | 6:31 PM ET

After blood products maker CSL posted a 3 percent rise in first-half profit, Paul Perreault, MD and CEO, explains why he expects a 7 percent increase for full-year earnings.